On Friday, Biogen Inc (NASDAQ:BIIB)’s shares inclined 0.21% to $302.26.
A chronic disease like relapsing MS (RMS) can complicate common aspects of everyday life, and a new program from Biogen (BIIB) and SELF is helping women navigate these familiar issues. Reimagine MySelf, which is now available on SELF.com, provides women access to editorial content and an exclusive blog series where writers from the SELF Made Blogger Collective and experts offer their best practical advice on style, entertaining, travel, healthy eating and more. Personal tips for women living with RMS are incorporated into all of the blogs to ensure their relevance and meaning for those facing an RMS diagnosis.
Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It provides AVONEX to treat relapsing multiple sclerosis (MS); TYSABRI to treat relapsing forms of MS and Crohn’s disease; PLEGRIDY to treat relapsing MS; TECFIDERA to treat MS; FAMPYRA to improve walking in adult patients with MS; ALPROLIX to treat hemophilia B; ELOCTATE to treat hemophilia A; RITUXAN for treating non-Hodgkin’s lymphoma, rheumatoid arthritis, and chronic lymphocytic leukemia (CLL), in addition to two forms of ANCA-associated vasculitis; GAZYVA for the treatment of patients with formerly untreated CLL; and FUMADERM to treat severe plaque psoriasis in adult patients.
Discovery Communications Inc. (NASDAQ:DISCK)’s shares dropped -2.36% to $25.23.
Discovery Communications, Inc. (DISCK) Reports Second Quarter 2015 Results
Second Quarter 2015 Financial Highlights:
- Revenues raised 3% to $1,654 million (raised 11% not taking into account currency effects)
- Adjusted OIBDA reduced 2% to $680 million (raised 6% not taking into account currency effects)
- Adjusted EPS reduced 16% to $0.49 (raised 4% not taking into account currency effects)
- Repurchased $207 million worth of stock
Second Quarter Results
Second quarter revenues of $1,654 million raised $44 million, or 3%, over the second quarter a year ago, led by 5% growth at U.S. Netoperates and 1% growth at International Netoperates. Adjusted Operating Income Before Depreciation and Amortization(1) (“OIBDA”) reduced 2% to $680 million, as 7% growth at U.S. Netoperates was more than offset by an 11% decline at International Netoperates and a small operating loss at Education and Other. Total Company revenues grew 11% and Adjusted OIBDA grew 6% not taking into account currency effects, as changes in foreign currency exchange rates reduced both second quarter revenue and Adjusted OIBDA growth by 8%. Not taking into account currency effects, the impact of Eurosport(2) and the consolidation of Discovery Family, total Company revenues raised 4% and Adjusted OIBDA raised 3%.
Discovery Communications, Inc. operates as a media company. The company operates through U.S. Netoperates; International Netoperates; and Education and Other segments. It owns and operates television netoperates under the brands, such as Discovery, TLC, Animal Planet, Investigation Discovery, Science, Velocity, Discovery Family, American Heroes, Destination America, Discovery Life, Oprah Winfrey network, Eurosport, DMAX, and Discovery Kids.
At the end of Friday’s trade, Analog Devices, Inc. (NASDAQ:ADI))‘s shares dipped -2.19% to $53.96.
Analog Devices, Inc. ( ADI) a global leader in high-performance semiconductors for signal processing applications, recently declared that David Zinsner, Senior Vice President, Finance and CFO, and Ali Husain, Treasurer and Director of Investor Relations, will speak at the Citi Global Technology Conference on Tuesday, September 8, 2015 at 11 a.m. Eastern time.
Analog Devices, Inc. engages in the design, manufacture, and marketing of analog, mixed-signal, and digital signal processing integrated circuits (ICs) for use in industrial, automotive, consumer, and communication markets worldwide. It offers signal processing products that convert, condition, and process real-world phenomena, such as temperature, pressure, sound, light, speed, and motion into electrical signals.
Century Aluminum Co (NASDAQ:CENX), ended its Friday’s trading session with 1.72% gain, and closed at $5.33.
Century Aluminum Company ( CENX) stated a net loss of $33.9 million ($0.39 per common share) for the second quarter of 2015. Results comprise a $30.9 million impairment charge ($0.35 per common share) related to the permanent closure of our Ravenswood smelter and a $25.7 million charge ($0.30 per common share) for lower of cost or market inventory adjustments. Results were also negatively influenced by $11.7 million ($0.13 per common share) in costs related to the labor disruption at our Hawesville smelter. Lastly, results comprise a $10.3 million ($0.12 per common share) unrealized gain on the fair value of contingent consideration related to the acquisition of the remaining 50.3% interest of Mt. Holly. After consideration of these items, the company stated adjusted net income of $24.1 million and adjusted earnings per share of $0.25.
For the second quarter of 2014, Century stated net income of $20.3 million ($0.21 per common share). Results were negatively influenced by a charge of $0.5 million ($0.01 per common share) for the finalization of a legal settlement.
Sales for the second quarter of 2015 were $523.5 million contrast with $458.3 million for the second quarter of 2014. Shipments of primary aluminum for the second quarter of 2015 were 233,950 tonnes contrast with 216,044 tonnes shipped in the second quarter of 2014.
Century Aluminum Company, together with its auxiliaries, produces primary aluminum in the United States and Iceland. It produces standard grade and value-added primary aluminum products; and carbon products, such as anodes and cathodes. The company was founded in 1995 and is headquartered in Chicago, Illinois.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
